AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionAdvocate Group Llc
Latest Disclosed Ownership75,672 shares
Latest Disclosed Value $ 16,458,005
Advocate Group Llc reports 0.71% decrease in ownership of 4AB / AbbVie Inc.

On April 13, 2026 - Advocate Group Llc filed a 13F-HR form disclosing ownership of 75,672 shares of AbbVie Inc. (DE:4AB) valued at $14,029,589 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 76,212 shares of AbbVie Inc.. This represents a change in shares of -0.71% during the quarter. The current value of the position is $14,264,172 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F ABBVIE COM 00287Y109 75,672 -540 -0.71 16,458 -5.48 2.5742
2026-01-20 2025-12-31 13F ABBVIE COM 00287Y109 76,212 -6,035 -7.34 17,414 -8.56 2.8170
2025-10-20 2025-09-30 13F ABBVIE COM 00287Y109 82,247 945 1.16 19,043 26.19 3.1306
2025-07-25 2025-06-30 13F ABBVIE COM 00287Y109 81,302 2,163 2.73 15,091 -8.99 2.6977
2025-04-22 2025-03-31 13F ABBVIE COM 00287Y109 79,139 1,193 1.53 16,581 19.71 3.0240
2025-01-21 2024-12-31 13F ABBVIE COM 00287Y109 77,946 652 0.84 13,851 -9.26 2.6081
2024-10-09 2024-09-30 13F ABBVIE COM 00287Y109 77,294 295 0.38 15,264 15.58 2.7675
2024-07-10 2024-06-30 13F ABBVIE COM 00287Y109 76,999 -397 -0.51 13,207 -6.29 2.6595
2024-04-25 2024-03-31 13F ABBVIE COM 00287Y109 77,396 -816 -1.04 14,094 16.28 2.8022
2024-01-19 2023-12-31 13F ABBVIE COM 00287Y109 78,212 -1,011 -1.28 12,121 2.64 2.6019
2023-10-17 2023-09-30 13F ABBVIE COM 00287Y109 79,223 908 1.16 11,809 11.91 2.7366
2023-07-20 2023-06-30 13F ABBVIE COM 00287Y109 78,315 3,071 4.08 10,551 -12.01 2.3216
2023-04-19 2023-03-31 13F ABBVIE COM 00287Y109 75,244 -3,007 -3.84 11,992 -5.18 2.6183
2023-01-18 2022-12-31 13F ABBVIE COM 00287Y109 78,251 -2,176 -2.71 12,646 17.16 2.7228
2022-10-19 2022-09-30 13F ABBVIE COM 00287Y109 80,427 -3,687 -4.38 10,794 -16.22 2.6680
2022-07-27 2022-06-30 13F ABBVIE COM 00287Y109 84,114 84,114 12,883 2.9995
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.